Cancer Research Process in the News
Read media coverage of the cancer research process and the challenges scientists face in their search for more effective treatments and, ultimately, a cure. If you would like to submit an article for inclusion on this page, contact NCI’s Office of Advocacy Relations.
Target Cancer - Series
New York Times 2010
The Target Cancer series chronicles the first human trial of an experimental cancer drug, exploring the challenges that face the doctors and patients who test it.
- January 19, 2011 - Drug to Fight Melanoma Prolonged Life in Trial
The results pave the way for Roche, the manufacturer, to seek approval to market the drug.
- December 26, 2010 - Enlisting the Dying for Clues to Save Others
Researchers are increasingly relying on the very patients a new class of cancer drugs failed to cure.
- September 19, 2010 - New Drugs Stir Debate on Rules of Clinical Trials
Two cousins developed the same lethal cancer; only one could take part in an experimental drug trial. Critics say that new science behind the drugs has eclipsed the old rules, and ethics, of testing them.
- February 24, 2010 - A Drug Trial Cycle: Recovery, Relapse, Reinvention
When patients on an experimental drug trial relapsed, researchers pushed pharmaceutical companies to collaborate.
- February 22, 2010 - A Roller Coaster Chase for a Cure
At what may be a watershed moment in understanding genetic changes that cause cancer, a small band of doctors is doggedly testing a drug known as PLX4032.
Scientists Develop Model that Advances Understanding of the Process of Cancer Metastasis
In a new technical advance, NCI scientists have successfully designed, implemented, and validated a model that allows scientists to explore—in real-time—the progression of cancer as it metastasizes in the mouse lung. Understanding the mechanisms of how metastasis works is an important step in stopping its progression.
Ten Years On — The Human Genome and Medicine
New England Journal of Medicine 2010
NCI Director Harold Varmus, M.D., analyzes the status of genomic medicine 10 years after the scientists seeking to decode the human genome had announced that a draft sequence had been completed. The article also serves as an introduction to Genomic Medicine — An Updated Primer by Drs. W. Gregory Feero, Alan E. Guttmacher, and Francis S. Collins.
Desperately Seeking Cures
Why do most promising, new avenues for treatment end before they enter the clinic? Find out why translating basic discoveries into human therapies is so difficult.
War Against Cancer Has More Than One Target
The Washington Post 2010
Cancer isn’t just one disease, which makes fighting it an uphill battle.
Focusing the Research Enterprise on the Patient
NCI Cancer Bulletin 2010
High-quality, patient-centered care occurs when the ultimate needs of the patient are met throughout treatment. Learn how comparative-effectiveness research will help make this situation a reality.
Libraries of Flesh: The Sorry State of Human Tissue Storage
Biospecimens — human tissue, blood, or plasma — fuel the cancer research enterprise. But what happens when those samples don’t meet the high standards needed for testing?
Progress toward Public Access to Science
PLoS Biology 2008
By taking this step, the NIH will join other funding agencies which have recently required their investigators to deposit publications in public libraries.
The New Era in Cancer Research
Achieving the medical promise of this new era in cancer research will require a deeper understanding of the biology of cancer and imaginative application of new knowledge in the clinic, as well as political, social, and cultural changes.
The Law of Unintended Consequences
In 1980, a new law launched the biotech industry. It was supposed to usher in a new era of innovation. So why are medical miracles in such short supply?
Why We're Losing the War on Cancer [and How to Win It]
To win the fight, we may need to change the way we think about — and fund — cancer research.